naringenin has been researched along with Necrosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awale, S; Esumi, H; Kadota, S; Li, F; Onozuka, H; Tezuka, Y | 1 |
| Burade, V; Goswami, S; Pateliya, B | 1 |
| Chtourou, Y; Fetoui, H; Gdoura, R; Makni, M; Slima, AB | 1 |
| Cheng, KW; Fan, D; Hu, S; Li, ET; Ru, B; Wang, M; Zhang, J; Zhao, Y | 1 |
| Ishikawa, M; Kanno, S; Koiwai, K; Ohtake, T; Tomizawa, A; Ujibe, M | 1 |
5 other study(ies) available for naringenin and Necrosis
| Article | Year |
|---|---|
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Necrosis; Nutritional Requirements; Pancreatic Neoplasms; Phytotherapy; Plant Extracts; Propolis; Sensitivity and Specificity | 2008 |
Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Female; Flavanones; Humans; Interleukin-1beta; Male; Metformin; Mice, Inbred BALB C; Mice, Nude; Necrosis; Triple Negative Breast Neoplasms; Troponin I; Tumor Burden; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2021 |
Naringenin protects cardiac hypercholesterolemia-induced oxidative stress and subsequent necroptosis in rats.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; DNA Damage; Flavanones; Heart; Hypercholesterolemia; Male; Membrane Potential, Mitochondrial; Myocardium; Necrosis; Oxidative Stress; Protective Agents; Rats; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2015 |
6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells.
Topics: Autophagy; Autophagy-Related Protein 7; Beclin-1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Enzyme Inhibitors; Farnesol; Flavanones; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HCT116 Cells; HT29 Cells; Humans; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Necrosis; Phosphatidylinositol 3-Kinases; Protein Methyltransferases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; ras Proteins; Salicylates; TOR Serine-Threonine Kinases | 2016 |
Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspases; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Flavanones; HL-60 Cells; Humans; Intracellular Membranes; Leukemia, Promyelocytic, Acute; Membrane Potentials; Mitochondria; Necrosis; NF-kappa B | 2006 |